MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 109 filers reported holding MIRUM PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,605,844 | +269.3% | 114,109 | +202.4% | 0.02% | +280.0% |
| Q2 2023 | $976,334 | +333.9% | 37,740 | +253.1% | 0.01% | +400.0% |
| Q3 2022 | $225,000 | -20.2% | 10,689 | -26.1% | 0.00% | -50.0% |
| Q2 2022 | $282,000 | -44.4% | 14,473 | -37.1% | 0.00% | 0.0% |
| Q1 2022 | $507,000 | +24.0% | 23,007 | -10.2% | 0.00% | 0.0% |
| Q4 2021 | $409,000 | – | 25,618 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RiverVest Venture Management LLC | 1,621,118 | $38,939,254 | 45.05% |
| NEA Management Company, LLC | 4,186,243 | $100,553,557 | 6.95% |
| Frazier Life Sciences Management, L.P. | 3,860,107 | $92,719,770 | 6.71% |
| Prosight Management, LP | 567,826 | $13,639,181 | 6.47% |
| TANG CAPITAL MANAGEMENT LLC | 1,170,000 | $28,103,400 | 4.19% |
| Highlander Partners, L.P. | 122,980 | $2,953,980 | 4.00% |
| Novo Holdings A/S | 1,684,193 | $40,454,316 | 2.67% |
| CADIAN CAPITAL MANAGEMENT, LP | 734,922 | $17,652,826 | 1.10% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,032,335 | $48,816,687 | 1.09% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 105,939 | $2,544,655 | 1.05% |